跳至主要内容
临床试验/IRCT20240125060804N1
IRCT20240125060804N1招募中3 期

Investigating the effect of zinc supplementation on the levels of oxidative stress and inflammation markers and glucose homeostasis in overweight or obese patients with metabolic syndrome

Islamic Azad University0 个研究点目标入组 60 人开始时间: 待定最近更新:

试验速览

阶段
3 期
状态
招募中
入组人数
60

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 70 years(—)
性别
All

入选标准

  • Age over 18 to 70 years old
  • Definite diagnosis of metabolic syndrome based on clinical symptoms and laboratory findings.
  • Overweight or obesity (BMI above 25)
  • Obtaining written informed consent from patients

排除标准

  • Taking zinc supplements at least three months before starting the study
  • The need to take blood sugar and lipid lowering drugs according to the doctor's opinion
  • History of other diseases related to oxidative stress and inflammation such as cardiovascular diseases, autoimmune diseases, types of diabetes, IBD, asthma, cancer, kidney and liver diseases, Infectious diseases
  • Smoking and alcohol consumption

研究者

相似试验